SARAH POLOW: Open Payments
NPI 1518924521 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 28 payments from 16 companies in 2025. Trend: 2023 $602 · 2024 $828 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Tonix Medicines, Inc. | 1 | $84 |
| PFIZER INC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| ABBVIE INC. | 2 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| Amgen Inc. | 2 | $36 |
| Medtronic, Inc. | 1 | $33 |
Products named: CAPLYTA, VRAYLAR, XIFAXAN, PREVNAR 20, XTAMPZA, JARDIANCE, INCEPTIV, ELIQUIS.
Industry payments across GA — which companies pay providers there.
